Notably, miR-146a-5p targets SMN1, and the data implicated the involvement of NOTCH, nuclear factor kappa B (NF-κB), and Toll-like receptor signaling pathways in SMA pathophysiology [22]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.